Columbia, MD – (March 16, 2015) – ACell, Inc. today announced the selection of David Elliot as Vice President, Marketing. In this role, Elliot will lead all ACell marketing initiatives and offer strategic direction to advance ACell as a leading regenerative medicine company.
“David has the right combination of diverse marketing and executive leadership experience,” said James A. D’Orta, MD, Chief Executive Officer. “There is tremendous opportunity for ACell to expand our reach and help more patients, and David will be a vital part of the leadership team driving that growth.”
Elliot has more than 20 years of experience in commercialization, market development, sales and marketing leadership, and strategic planning. Elliot previously served as Vice President, Academic Affairs and Marketing Services at St. Jude Medical. He has held leadership positions at a range of medical device companies including Tyrx, Inc., Valam, VistaCare (now Odyssey/Gentiva), VasClip, Guidant, and Eli Lilly.
“I am excited to join ACell and help shape our future marketing strategy as we transform the standard of care and help more patients with our core technology,” said Elliot. “Effectively communicating our corporate and product capabilities to health care providers, administrators, and payers will be a major driver of the company’s continued expansion, and I look forward to working with the entire ACell team to make that happen.”
About ACell, Inc.
ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN. For more information, call 800-826-2926 or visit www.acell.com.
MatriStem products contain the epithelial basement membrane from porcine urinary bladder, and are based on the proprietary ECM composition generally referred to in scientific literature as urinary bladder matrix, or UBM. UBM is a segment of tissue layers that facilitates a constructive tissue remodeling response by the patient’s body. MatriStem products are indicated for use in general surgery, gynecological surgery, and in the management of a wide range of wounds. Refer to the IFU supplied with each product for indications, contraindications and precautions. All MatriStem products are made in the USA.Return to News